Clinical Trials on Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)

Total 9 results

Shanghai Children's Medical Center

Not yet recruiting

SCMC Trial on KHE With KMP (V.2020) (SCMC-KK2020)

Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)

China
West China Hospital

Completed

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

Kaposiform Hemangioendothelioma | Kasabach Merritt Phenomenon

China
Boston Children's Hospital
Pfizer

Terminated

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Kasabach-Merritt Syndrome | Tufted Angioma | Kaposiform Hemangioendothelioma (KHE)

United States
Children's Hospital of Fudan University

Completed

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Hemangioma | Kaposiform Hemangioendothelioma

China
Children's Hospital of Fudan University

Recruiting

The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

Kaposiform Hemangioendothelioma

China
West China Hospital

Recruiting

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

Hemangioendothelioma

China
West China Hospital

Completed

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

Kaposiform Hemangioendothelioma

China
Children's Hospital of Fudan University

Completed

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Kaposiform Hemangioendothelioma | Kasabach-Merritt Syndrome

China
West China Hospital

Recruiting

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

China

Clinical Trials on Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations